Literature DB >> 23016880

Prognostic significance of fibroblastic foci in usual interstitial pneumonia and non-specific interstitial pneumonia.

Taishi Harada1, Kentaro Watanabe, Kazuki Nabeshima, Makoto Hamasaki, Hiroshi Iwasaki.   

Abstract

BACKGROUND AND
OBJECTIVE: Fibroblastic foci (FF) composed of an accumulation of fibroblasts or myofibroblasts may be related to the progression of pulmonary fibrosis leading to respiratory insufficiency. Several studies have shown that the number of FF is a significant prognostic factor in usual interstitial pneumonia (UIP). The purpose of the present study was to examine whether the extent of FF is related to impairment of respiratory function and prognosis in patients with biopsy-proven fibrosing interstitial pneumonia, including UIP and fibrotic non-specific interstitial pneumonia (fNSIP).
METHODS: Fifty patients with histologically confirmed interstitial pneumonia including UIP or fNSIP were investigated, and correlations between FF and pulmonary function were evaluated. FF area was calculated as the proportion of total area (%FF) and the number of FF (FF/cm(2)) in the whole histological specimen from each patient.
RESULTS: The UIP group showed significantly higher %FF and FF/cm(2) than the fNSIP group. When UIP and fNSIP patients were analysed together, the group of patients who had died (death group) revealed significantly higher %FF and FF/cm(2) compared with the group of survivors, and the impairment of vital capacity and diffusing capacity of carbon monoxide was correlated with %FF and FF/cm(2).
CONCLUSIONS: FF correlated with impaired pulmonary function and may be a useful parameter to predict prognosis in patients with UIP and fNSIP.
© 2012 The Authors. Respirology © 2012 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Year:  2013        PMID: 23016880     DOI: 10.1111/j.1440-1843.2012.02272.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  19 in total

1.  Serial automated quantitative CT analysis in idiopathic pulmonary fibrosis: functional correlations and comparison with changes in visual CT scores.

Authors:  Joseph Jacob; Brian J Bartholmai; Srinivasan Rajagopalan; Maria Kokosi; Ryoko Egashira; Anne Laure Brun; Arjun Nair; Simon L F Walsh; Ronald Karwoski; Athol U Wells
Journal:  Eur Radiol       Date:  2017-09-29       Impact factor: 5.315

2.  Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.

Authors:  Ryota Kanemaru; Fumiyuki Takahashi; Motoyasu Kato; Yoichiro Mitsuishi; Ken Tajima; Hiroaki Ihara; Moulid Hidayat; Aditya Wirawan; Yoshika Koinuma; Daisuke Hayakawa; Shigehiro Yagishita; Ryo Ko; Tadashi Sato; Norihiro Harada; Yuzo Kodama; Fariz Nurwidya; Shinichi Sasaki; Shin-Ichiro Niwa; Kazuhisa Takahashi
Journal:  Lung       Date:  2018-06-20       Impact factor: 2.584

Review 3.  The state of the art for artificial intelligence in lung digital pathology.

Authors:  Vidya Sankar Viswanathan; Paula Toro; Germán Corredor; Sanjay Mukhopadhyay; Anant Madabhushi
Journal:  J Pathol       Date:  2022-06-20       Impact factor: 9.883

4.  Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis.

Authors:  Yoichiro Aoshima; Yasunori Enomoto; Shigeki Muto; Shiori Meguro; Hideya Kawasaki; Isao Kosugi; Tomoyuki Fujisawa; Noriyuki Enomoto; Naoki Inui; Yutaro Nakamura; Takafumi Suda; Toshihide Iwashita
Journal:  Lung       Date:  2021-03-26       Impact factor: 2.584

5.  Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease.

Authors:  Simon L F Walsh; Athol U Wells; Nicola Sverzellati; Anand Devaraj; Jan von der Thüsen; Samuel A Yousem; Thomas V Colby; Andrew G Nicholson; David M Hansell
Journal:  BMC Med       Date:  2015-09-24       Impact factor: 8.775

6.  Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis.

Authors:  Mark G Jones; Aurélie Fabre; Philipp Schneider; Francesco Cinetto; Giacomo Sgalla; Mark Mavrogordato; Sanjay Jogai; Aiman Alzetani; Ben G Marshall; Katherine M A O'Reilly; Jane A Warner; Peter M Lackie; Donna E Davies; David M Hansell; Andrew G Nicholson; Ian Sinclair; Kevin K Brown; Luca Richeldi
Journal:  JCI Insight       Date:  2016-04-21

Review 7.  Pathology of Idiopathic Interstitial Pneumonias.

Authors:  Mikiko Hashisako; Junya Fukuoka
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2016-02-29

8.  Prognostic factors in interstitial lung disease associated with primary Sjögren's syndrome: a retrospective analysis of 33 pathologically-proven cases.

Authors:  Yasunori Enomoto; Tamiko Takemura; Eri Hagiwara; Tae Iwasawa; Yuh Fukuda; Noriyo Yanagawa; Fumikazu Sakai; Tomohisa Baba; Shouhei Nagaoka; Takashi Ogura
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

9.  Induction of stemlike cells with fibrogenic properties by carbon nanotubes and its role in fibrogenesis.

Authors:  Sudjit Luanpitpong; Liying Wang; Amruta Manke; Karen H Martin; Amanda Gatesman Ammer; Vincent Castranova; Yong Yang; Yon Rojansakul
Journal:  Nano Lett       Date:  2014-05-30       Impact factor: 11.189

10.  FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis.

Authors:  Hamza M Al-Tamari; Swati Dabral; Anja Schmall; Pouya Sarvari; Clemens Ruppert; Jihye Paik; Ronald A DePinho; Friedrich Grimminger; Oliver Eickelberg; Andreas Guenther; Werner Seeger; Rajkumar Savai; Soni S Pullamsetti
Journal:  EMBO Mol Med       Date:  2018-02       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.